A newly filed Periodic Transaction Report shows Hon. Richard Dean Dr McCormick, a member of the U.S. House of Representatives, sold shares of UnitedHealth Group Incorporated Common Stock (UNH) on July 30, 2026. The transaction, valued between $1,001 and $15,000, was disclosed under the STOCK Act, which requires members of Congress to report trades made by themselves, their spouses, or dependent children within 45 days of execution.
According to the filing, the sale was made personally by Rep. McCormick and was held through a Growth Partners Roth IRA. Our internal classification tags this transaction as a ‘congress sale’ signal, meaning it reflects a reduction in exposure to the underlying stock rather than a new or increased position.
A Notable Timing Overlap
What makes this disclosure worth flagging is its proximity to another sale of the same stock. Company insider Conway Patrick Hugh, associated with UnitedHealth Group, sold approximately $205,000 worth of UNH shares on August 5, 2026 — just six days after Rep. McCormick’s filed transaction date. While insider Form 4 filings and congressional STOCK Act disclosures are governed by entirely separate reporting regimes, seeing both a member of Congress and a company insider offload UNH shares within a 30-day window is the kind of overlap our tracking tools are built to surface.
It is important to be clear about what this does and does not mean. Neither disclosure, on its own or together, implies any wrongdoing. STOCK Act reporting is a legal requirement for federal lawmakers, and Form 4 filings are a routine obligation for corporate insiders. Both transactions are simply part of the public record, and the timing overlap is presented here as a data point rather than an allegation.
For readers tracking broader institutional positioning around names like UNH, it can also be useful to compare congressional and insider activity against how large asset managers are adjusting their own holdings. Our ongoing coverage of Veritas Asset Management LLP’s quarterly 13F portfolio moves offers one such perspective on how institutional money tends to shift alongside headline-driven stocks like UnitedHealth.
Rep. McCormick’s office has not issued any additional public comment beyond the filing itself. WhoIsBuyingNow.com will continue monitoring subsequent disclosures involving UNH, both from Capitol Hill and from company insiders, as they are filed.